Guanfacine: Effects of long‐term treatment and withdrawal.

Noradrenaline Release from Isolated Nerve Granules

1961 • 1,005 citations

Improved Technique for the Fluorimetric Estimation of Catecholamines

1961 • 978 citations

A sensitive radioenzymatic assay for norepinephrine in tissues and plasma

1975 • 475 citations

Clinical pharmacology and pharmacokinetics of clonidine

1976 • 275 citations

Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients

1970 • 169 citations

CLONIDINE WITHDRAWAL IN HYPERTENSION

1977 • 147 citations

Effects of Clonidine Withdrawal: Possible Mechanisms and Suggestions for Management

1973 • 132 citations

Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension

1977 • 94 citations

Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).

1975 • 80 citations

Some observations on the inhibition of salivation by St 155 [2-(2,5-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres®, Catapresan®]

1969 • 51 citations

A new centrally action antihypertensive agent guanfacine (BS 100-141).

1977 • 14 citations

Studies in the rat on the haemodynamic overshoot response to withdrawal of guanfacine or clonidine treatment

1979 • 10 citations

Long‐term treatment of hypertension with guanfacine alone and in combination therapy.

1980 • 6 citations

S 100-141 A CENTRALLY ACTING ANTIHYPERTENSIVE DRUG: EFFECTS ON BLOOD PRESSURE AND PLASMA AND URINARY NORADRENALINE IN ESSENTIAL HYPERTENSION

1978 • 5 citations

COMPARISON OF CARDIOVASCULAR AND OTHER EFFECTS OF CLONIDINE AND BS 100-141

1978 • 3 citations

Comparison of the actions of central and peripheral administration of clonidine and BS 100-141 in the rabbit [proceedings].

1978 • 2 citations

Deleted Work

1955 • 0 citations